Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price ...

Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

NeuroPace, Inc. (Nasdaq: NPCE) today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $10.00 per share. All of the shares ...

Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...

Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of United Therapeutics in a research report ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

NeuroPace (Nasdaq:NPCE) today announced that it intends to sell common stock in an underwritten public offering worth $65 ...

Additionally given a 30-day option to buy up to an extra 975,000 shares at the same price are underwriters. About $49.5 million of the net proceeds would be used by NeuroPace to buy 5,270,845 shares ...

Incorporated (NYSE: ELAN) shares have reached a 52-week low, dipping to $11.11, as the company faces a tumultuous market environment. With a market capitalization of $5.55 billion and a beta of 1.42, ...